Synthesis of carbon quantum dots for application of alleviating amyloid-β mediated neurotoxicity

Colloids Surf B Biointerfaces. 2022 Apr:212:112373. doi: 10.1016/j.colsurfb.2022.112373. Epub 2022 Jan 26.

Abstract

Alzheimer's disease (AD) has been an intractable neurodegenerative disease among the elderly in the worldwide. One of the important pathogenic factors in AD is the aggregation of amyloid-β 1-42 (Aβ42) in AD patients' brain. Inhibition of Aβ peptide aggregation is considered as one of the effective approaches against AD. Herein, a pulsed laser ablation (PLA) method is used to fabricate ultra-small carbon quantum dots (C-QDs) with uniform size. The reduced Aβ42 aggregation by the C-QDs was confirmed by transmission electron microscopy (TEM), thioflavin T assay and circular dichroism (CD) spectroscopy. The results of cell viability experiments showed that the presence of the C-QDs could significantly reduce the cytotoxicity of Aβ42. Furthermore, in vivo studies demonstrate that C-QDs can decrease Aβ42 deposits and promote the biological activity of an AD model of Caenorhabditis elegans CL2006. This work demonstrates the viability of using ultrasmall C-QDs to inhibit amyloid-β aggregation and alleviate amyloid-β mediated neurotoxicity.

Keywords: Alzheimer’s disease; Aβ42 aggregation; Aβ42 inhibitors; Carbon quantum dots; Pulsed laser ablation method.

MeSH terms

  • Aged
  • Alzheimer Disease* / drug therapy
  • Amyloid beta-Peptides / chemistry
  • Carbon / pharmacology
  • Humans
  • Neurodegenerative Diseases*
  • Peptide Fragments / chemistry
  • Quantum Dots*

Substances

  • Amyloid beta-Peptides
  • Peptide Fragments
  • Carbon